ARCADIA BIOSCIENCES INC

RKDANASDAQ

🏆 #4819 by market capEarnings Aug 19US Equity

$0.75▲ $0.09 (+11.94%)

Live

1h—

24h▲ 11.9%

7d▲ 12.8%

14d▲ 13.2%

30d▲ 23.3%

1y▼ 82.1%

🏦Market Cap

$1M

Small Cap

📈Revenue Growth (YoY)

-3.7%

Declining

📊Gross Margin

34.5%

Moderate

💵FCF Margin

-89.3%

Thin

⚖️P/S Ratio

0.2x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $0.75 – $0.76
52-Week Range: $0.59 – $6.71
Volume: $2.71B
Avg Volume: $2.81B
Shares Outstanding: 1.5M
Next Earnings: Sep 7, 2026

Fundamentals Snapshot

Annual Revenue: $5M
Last Q Revenue: $1M
P/E Ratio: -0.1
P/S Ratio: 0.2x
EPS (TTM): $-6.81
Dividend Yield: 0.00%

Why Investors Own RKDA

✓High-growth profile — revenue up -3.1% YoY with expanding US Equity exposure.
✓Healthy economics — 66% gross margin and 26% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$5M▼ −1.6% YoY

Gross Margin (TTM)

65.5%▲ +0.3% YoY

Operating Income (TTM)

$1M▼ −1.6% YoY

Free Cash Flow (TTM)

$1M▼ −1.6% YoY

About ARCADIA BIOSCIENCES INC

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.

🦦